Publications by authors named "Patricia Barros-Garcia"

Objectives: The objective of this study was to assess the association between serological markers and changes of the intestinal mucosa in children with celiac disease (CD).

Methods: Clinical data from CD patients under 15 years old were collected from the participating centers in an on-line multicenter nationwide observational Spanish registry called REPAC-2 (2011-2017). Correlation between anti-tissue transglutaminase antibodies (t-TGA) levels and other variables, including mucosal damage and clinical findings (symptoms, age, and gender), was assessed.

View Article and Find Full Text PDF

Background: Ultra-short coeliac disease (USCD) is a novel celiac disease (CD) subtype limited to the duodenal bulb (D1). HLA haplotypes and flow cytometry have not been assessed yet.

Aims: To compare genetic, clinical, serologic, histopathologic and inmmunophenotypic parameters between USCD and conventional celiac disease (CCD) patients.

View Article and Find Full Text PDF

Objectives: Over the last several decades, there has been a tendency towards a predominance of less symptomatic forms of coeliac disease (CD) and an increase in the patient age at diagnosis. This study aimed to assess the clinical presentation and diagnostic process of paediatric CD in Spain.

Methods: A nationwide prospective, observational, multicentre registry of new paediatric CD cases was conducted from January 2011 to June 2017.

View Article and Find Full Text PDF

Diagnostic delay (DD) is especially relevant in children with inflammatory bowel disease, leading to potential complications. We examined the intervals and factors for DD in the pediatric population of Spain. We conducted a multicentric prospective study, including 149 pediatric inflammatory bowel disease patients, obtaining clinical, anthropometric, and biochemical data.

View Article and Find Full Text PDF
Article Synopsis
  • Exclusive enteral nutrition (EEN) is more effective than corticosteroids for achieving mucosal healing in children with Crohn's disease, without the negative side effects of steroids.
  • A study covering 222 newly diagnosed pediatric patients found that 83% achieved clinical remission after an average of 8 weeks of EEN, with significant reductions in faecal calprotectin levels.
  • Factors predicting a better response to EEN include specific scores on the Crohn's disease activity index, lower calprotectin levels, elevated CRP, and ileal involvement, suggesting EEN should be first-line treatment for pediatric Crohn's disease.
View Article and Find Full Text PDF

Objectives: Rising trends in eosinophilic esophagitis (EoE) have been repeatedly linked to declining Helicobacter pylori (H. pylori) infection, mostly in retrospective studies. We aimed to prospectively evaluate this inverse association.

View Article and Find Full Text PDF